195 related articles for article (PubMed ID: 3485651)
1. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients.
Fanti P; Smith AJ; Price PA; Reitz RE; Malluche HH
J Clin Endocrinol Metab; 1986 May; 62(5):869-73. PubMed ID: 3485651
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
Malluche HH; Faugere MC; Fanti P; Price PA
Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
[TBL] [Abstract][Full Text] [Related]
4. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up.
Coen G; Mazzaferro S; Bonucci E; Taggi F; Ballanti P; Bianchi AR; Donato G; Massimetti C; Smacchi A; Cinotti GA
Kidney Int; 1985 Nov; 28(5):783-90. PubMed ID: 3878905
[TBL] [Abstract][Full Text] [Related]
5. Determinants of serum 1,25(OH)2D levels in renal disease.
Cheung AK; Manolagas SC; Catherwood BD; Mosely CA; Mitas JA; Blantz RC; Deftos LJ
Kidney Int; 1983 Jul; 24(1):104-9. PubMed ID: 6604833
[TBL] [Abstract][Full Text] [Related]
6. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
Epstein S; Traberg H; Raja R; Poser J
J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cadmium-induced osteopenia by measurement of serum bone Gla protein, parathyroid hormone, and 1 alpha,25-dihydroxyvitamin D.
Kido T; Honda R; Tsuritani I; Ishizaki M; Yamada Y; Nogawa K; Nakagawa H; Dohi Y
J Appl Toxicol; 1991 Jun; 11(3):161-6. PubMed ID: 1918789
[TBL] [Abstract][Full Text] [Related]
8. Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat.
Ismail F; Epstein S; Fallon MD; Thomas SB; Reinhardt TA
Endocrinology; 1988 Feb; 122(2):624-30. PubMed ID: 3257440
[TBL] [Abstract][Full Text] [Related]
9. Perinatal serum bone Gla-protein and vitamin D metabolites in preterm and fullterm neonates.
Delmas PD; Glorieux FH; Delvin EE; Salle BL; Melki I
J Clin Endocrinol Metab; 1987 Sep; 65(3):588-91. PubMed ID: 3497940
[TBL] [Abstract][Full Text] [Related]
10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
11. Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.
Miki T; Nakatsuka K; Nishizawa Y; Emoto M; Morita A; Tabata T; Matsushita Y; Inoue T; Morii H
Endocrinol Jpn; 1991 Oct; 38(5):479-83. PubMed ID: 1843267
[TBL] [Abstract][Full Text] [Related]
12. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
13. Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
Theofan G; Price PA
Mol Endocrinol; 1989 Jan; 3(1):36-43. PubMed ID: 2464756
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum bone Gla protein and urinary gamma-Gla as biochemical markers in primary hyperparathyroidism.
Yoneda M; Takatsuki K; Oiso Y; Takano T; Kurokawa M; Ota A; Tomita A; Ohno T; Okano K; Kanazawa T
Endocrinol Jpn; 1986 Feb; 33(1):89-94. PubMed ID: 3487445
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat.
Weisinger JR; Favus MJ; Langman CB; Bushinsky DA
J Bone Miner Res; 1989 Dec; 4(6):929-35. PubMed ID: 2610024
[TBL] [Abstract][Full Text] [Related]
16. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
[TBL] [Abstract][Full Text] [Related]
17. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action.
Eastell R; Yergey AL; Vieira NE; Cedel SL; Kumar R; Riggs BL
J Bone Miner Res; 1991 Feb; 6(2):125-32. PubMed ID: 2028834
[TBL] [Abstract][Full Text] [Related]
18. The dichotomy in the effects of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats.
Wientroub S; Price PA; Reddi AH
Calcif Tissue Int; 1987 Mar; 40(3):166-72. PubMed ID: 3105848
[TBL] [Abstract][Full Text] [Related]
19. Differences in serum bone GLA protein with age and sex.
Epstein S; Poser J; McClintock R; Johnston CC; Bryce G; Hui S
Lancet; 1984 Feb; 1(8372):307-10. PubMed ID: 6141381
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma bone GLA protein during treatment of bone disease.
Deftos LJ; Parthemore JG; Price PA
Calcif Tissue Int; 1982 Mar; 34(2):121-4. PubMed ID: 6805917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
